Degeneration of macula and posterior pole Clinical Trials

40 clinical trials for Degeneration of macula and posterior pole across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• SPARTACUS - PROSPECTIVE MULTICENTER STUDY TO DESCRIBE CHARACTERISTICS OF FARICIMAB PATIENTS WITH DME/NAMD PRETREATED WITH BEVACIZUMAB AND EFFECTIVENESS OF FARICIMAB IN A GERMAN REAL-WORLD COHORT — RECRUITING
• Development of performance-based endpoints for ophthalmology using digital data on smartphone use and activity (PERODI) — RECRUITING
• Assessment of Inflammatory and Chemical Parameters in Serum and Intraocular Samples of Patients with Various Ocular Diseases: The Homburg Inflammation Study (HIS) — RECRUITING
• observational comparative study: Intravitreal treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) with a bispecific antibody Vabysmo® (faricimab) vs. a classical anti-VEGF inhibitor Eylea® (aflibercept) in a treat-and-extend-regimen (FATE). — RECRUITING
• Evaluation of treat-and-extend-strategy-based ivom therapy — RECRUITING
• The prospective ADDA (Aachen, Düsseldorf*2, Alsdorf) register for eye surgery — RECRUITING
• A registry study on optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) biomarkers in retinal diseases — RECRUITING
• Psychometric properties of the Croatian version of the 25-item National Eye Institute Visual Function Questionnaire in patients with eye diseases — RECRUITING
• Micropulse treatment of vitreoretinal pathologies: retrospective and prospective study to collect patient data after subthreshold micropulse treatment — RECRUITING
• Sulzbach Geographic Atrophy Register in AMD Study (SuGAR AMD Study) — RECRUITING
• Retrospective and prospective analysis of functional and anatomical outcome following chromevitrectomy and peeling — RECRUITING
• Assessment of the supply situation of visually impaired patients with Low Vision Aids — RECRUITING
• Intravitreal Injection of Lucentis (Ranibizumab) after Pars Plana Vitrectomy and Subretinal Application of Recombinant Tissue Plasminogen Activator (rtPA) in Patients with Acute Submacular Hemorrhage as Complication of Exsudative Age-related Macular Degeneration (AMD). — RECRUITING
• Subthreshold Laser Titration: Compare Visibility Thresholds of Different Imaging Modalities — OTHER
• Retrospective analysis of clinical outcomes after switching from Ranibizumab to Aflibercept — OTHER
• Evaluation of innovative OCT techniques in comparison to conventional OCT — OTHER
• Study to evaluate health care situation and quality of life in patients with registered anti-VEGF treatment in neovascular AMD, diabetic macular edema or retinal vein occlusion — OTHER
• Switch of anti-VEGF agents (Bevacizumab and Ranibizumab) in non-responders to anti-VEGF treatment in AMD — OTHER
• Retrospective analysis of treatment with intravitreal injections in patients with AMD, DME and RVO in clinical practice — OTHER
• RESCAN 700 – Visualization of anterior and posterior ocular structures at extended OCT Scan depths > 2mm — OTHER
• A phone call guided visual acuity self assessment in AMD patients - prognostic value of standardized tests and comparison of recent usual care versus phone call-based screening strategy for maintaining the vision gain after Ranibizumab injections — OTHER
• Usability of a software for the categorisation of metamorphopsia (metacat) — OTHER
• Evaluation of functional outcomes and OCT-biomarkers after intravitreal dexamethasone implant for postoperative cystoid macular edema in vitrectomized eyes — OTHER
• Assessment of morphological and functional changes before and after vitrectomy for epiretinal membrane: randomized-controlled prospective comparison of patients with different endotamponade (air versus balanced salt solution). — NOT_YET_RECRUITING
• Prospective, early, intensified controll of central retinal thickness by optical coherence tomography to detect early recurrence of disease after treatment of neovascular Age-related macula degeneration (nAMD) by intravitreal injection — OTHER
• Investigation of genetic and non-genetic biomarkers in the aqueous humor of the eye in various diseases of the eye (age-related macular degeneration, diabetic macular edema and glaucoma) in comparison with controls. — NOT_YET_RECRUITING
• Reading speed during reading standardized single sentences and paragraphs in patients with maculopathy — OTHER
• A prospective, controlled, monocentric study comparing local complement activation in the aqueous humour of the eye in patients with and without oral supplemental zinc substitution as part of the dietary therapy of age-related macular degeneration (AMD) — OTHER
• Prospective, early, intensified controls of retinal thickness by optical coherence tomography to detect early recurrence of disease after treatment of degenerative and proliferative retinal diseases by intravitreal injection therapy — OTHER
• Effects of a special home reading training on the reading speed and secondarily on the emotional status of patients with age-related macular degeneration (AMD) — OTHER
• Characterizing visual function in Macular Telangiectasia Type 2 — NOT_YET_RECRUITING
• Risk factors for the progression of the fellow eye at patients with unilateral neovascular age-related maculadegeneration — NOT_YET_RECRUITING
• Influence of Junfeng BFS Water on Microcirculation — NOT_YET_RECRUITING
• The detection of intravitreal opsin concentrations in human eyes suffering from different alterations of the vitreomacular interface. — OTHER
• Indication for stereotactic radiotherapy of the macula with IRay® for wet age-related macular degeneration — NOT_YET_RECRUITING
• Intracameral concentrations of the fibrinolytic system components in patients with age-related macular degeneration. — OTHER
• Correlation of subjective visual parameters with morphologic parameters in reactivation of exsudative maculopathies — NOT_YET_RECRUITING
• Measurement of retinal nerve fibre layer after vitrectomy and internal limiting membrane peeling in patients with idiopathic epiretinal membrane and macular hole — NOT_YET_RECRUITING
• Comparison of outcome parameters of vitrectomy 23 gauge versus 20 gauge in patients with epiretinal membrane and macular hole — OTHER
• Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis — OTHER · PHASE4

Refine this search